This is a preview of subscription content, log in via an institution to check access.
Reference
Plumpton CO, et al. Cost Effectiveness of Pharmacogenetic Screening Prior to Initiation of Carbamazepine Treatment for Epilepsy. 16th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PND33, 2 Nov 2013.
Rights and permissions
About this article
Cite this article
Genetic testing prior to start of carbamazepine worthwhile. PharmacoEcon Outcomes News 692, 9 (2013). https://doi.org/10.1007/s40274-013-0894-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0894-4